Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Clinical trial NCT02847559 · RECRUITING

Trial details

NCT number: NCT02847559
Sponsor: Northwestern University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic (Malignant) Meningioma Atypical Meningioma Grade II Meningioma Grade III Meningioma Recurrent Meningioma Supratentorial Meningioma

Start date: 2016-08-01
Primary completion: 2026-09-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.